According to the FDA, the shot was approved without being tested for Omicron, which accounts for 99.9% of current U.S. COVID cases.
"Today, the U.S. Food and Drug Administration approved a second COVID-19 vaccine. The vaccine has been known as the Moderna COVID-19 Vaccine; the approved vaccine will be marketed as Spikevax for the prevention of COVID-19 in individuals 18 years of age and older," the FDA said in a widely-celebrated press release Monday.
The FDA noted in the small print of its approval letter that Spikevax and Moderna's emergency use authorization shot are "Legally distinct" products, adding that there are "Certain differences that do not impact safety or effectiveness." The same disclaimer was made when the FDA approved Pfizer's Comirnaty, which has never seen the light of day in the United States.
The FDA makes it clear that Spikevax has not been approved or tested for the Omicron variant, and that it was approved for former mutations that no longer exist in circulation.
So not only is the FDA approving what amounts to a ghost shot, they're acknowledging that this injection may only stand to allegedly combat a strain that no longer exists.
With mounting evidence that the shots seemingly have zero ability to prevent COVID-19 in the Omicron era, the FDA seems to have decided to carve out a special place for Moderna and Pfizer in its regulatory scrutiny processes.
So why aren't these FDA approved shots making their way to US customers.
https://dossier.substack.com/p/the-shell-game-continues-modernas
No comments:
Post a Comment